Search research articles
Contact Us
Filters
Showing results (241-250 of 264) with videos related to
Page
of 27
Sort By:
Metabolism: Clinical and Experimental
|
July 1, 1996
Acetyl-L-carnitine deficiency as a cause of altered nerve myo-inositol content, Na,K-ATPase activity, and motor conduction velocity in the streptozotocin-diabetic rat
M J Stevens, S A Lattimer, E L Feldman, et al.
Diabetes
|
February 1, 1997
Supplemental myo-inositol prevents L-fucose-induced diabetic neuropathy
A A Sima, J A Dunlap, E P Davidson, et al.
Acta Leprologica
|
January 1, 1991
[A survey of the prevalence of leprosy in 5 countries in central Africa]
J P Louis, M Merlin, R Josse, et al.
Diabetes
|
January 1, 1993
Abnormal agonist-stimulated cardiac parasympathetic acetylcholine release in streptozocin-induced diabetes
L Uccioli, P Magnani, P Tilli, et al.
Journal of Diabetes and Its Complications
|
July 1, 1993
Effect of hyperglycemia and the aldose reductase inhibitor tolrestat on sural nerve biochemistry and morphometry in advanced diabetic peripheral polyneuropathy. The Tolrestat Study Group
A A Sima, D A Greene, M B Brown, et al.
The Journal of Clinical Investigation
|
August 1, 1994
The linked roles of nitric oxide, aldose reductase and, (Na+,K+)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat
M J Stevens, J Dananberg, E L Feldman, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation
|
March 19, 2018
Myocardial Infarction Injury in Patients with Chronic Lung Disease Entering Pulmonary Rehabilitation: Frequency and Association with Heart Rate Parameters
Carmen A Sima, Benny C Lau, Carolyn M Taylor, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
May 23, 2000
Sorbitol and myo-inositol levels and morphology of sural nerve in relation to peripheral nerve function and clinical neuropathy in men with diabetic, impaired, and normal glucose tolerance
G Sundkvist, L B Dahlin, H Nilsson, et al.
Diabetes/Metabolism Reviews
|
October 1, 1993
Aldose reductase inhibitors: an approach to the treatment of diabetic nerve damage
D A Greene, A A Sima, M J Stevens, et al.
Neurology
|
October 1, 1994
Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-parkinsonism-amyotrophy complex
T Lynch, M Sano, K S Marder, et al.
Page
of 27
Search research articles
Search
Showing results (241-250 of 264) with videos related to
Sort By:
Page
of 27
Metabolism: Clinical and Experimental
|
July 1, 1996
Acetyl-L-carnitine deficiency as a cause of altered nerve myo-inositol content, Na,K-ATPase activity, and motor conduction velocity in the streptozotocin-diabetic rat
M J Stevens, S A Lattimer, E L Feldman, et al.
Diabetes
|
February 1, 1997
Supplemental myo-inositol prevents L-fucose-induced diabetic neuropathy
A A Sima, J A Dunlap, E P Davidson, et al.
Acta Leprologica
|
January 1, 1991
[A survey of the prevalence of leprosy in 5 countries in central Africa]
J P Louis, M Merlin, R Josse, et al.
Diabetes
|
January 1, 1993
Abnormal agonist-stimulated cardiac parasympathetic acetylcholine release in streptozocin-induced diabetes
L Uccioli, P Magnani, P Tilli, et al.
Journal of Diabetes and Its Complications
|
July 1, 1993
Effect of hyperglycemia and the aldose reductase inhibitor tolrestat on sural nerve biochemistry and morphometry in advanced diabetic peripheral polyneuropathy. The Tolrestat Study Group
A A Sima, D A Greene, M B Brown, et al.
The Journal of Clinical Investigation
|
August 1, 1994
The linked roles of nitric oxide, aldose reductase and, (Na+,K+)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat
M J Stevens, J Dananberg, E L Feldman, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation
|
March 19, 2018
Myocardial Infarction Injury in Patients with Chronic Lung Disease Entering Pulmonary Rehabilitation: Frequency and Association with Heart Rate Parameters
Carmen A Sima, Benny C Lau, Carolyn M Taylor, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
May 23, 2000
Sorbitol and myo-inositol levels and morphology of sural nerve in relation to peripheral nerve function and clinical neuropathy in men with diabetic, impaired, and normal glucose tolerance
G Sundkvist, L B Dahlin, H Nilsson, et al.
Diabetes/Metabolism Reviews
|
October 1, 1993
Aldose reductase inhibitors: an approach to the treatment of diabetic nerve damage
D A Greene, A A Sima, M J Stevens, et al.
Neurology
|
October 1, 1994
Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-parkinsonism-amyotrophy complex
T Lynch, M Sano, K S Marder, et al.
Page
of 27